Home | Welcome to Contract Pharma   
Last Updated Wednesday, September 3 2014
Print

Topics - Drug Delivery


Refine by Date:
From: To:
Published May 23, 2014
Will evaluate data and define the studies to further characterize safety and efficacy Read More »
Published May 19, 2014
To employ AntiOp’s nasal drug delivery expertise Read More »
Published April 3, 2014
Diabetes drug employs Novozymes VELTIS extension technology Read More »
By Kristin Brooks
Published March 26, 2014
Will use NanoStat platform for RSV and flu vaccine development Read More »
By Kristin Brooks
Published March 17, 2014
Will evaluate biOasis' Transcend brain delivery platform on preclinical assets Read More »
By Kristin Brooks
Published February 24, 2014
Designed to help improve consistency and reliability of intradermal injections Read More »
By Kristin Brooks
Published January 24, 2014
Aims to accelerate research and drug delivery technologies Read More »
By Kristin Brooks
Published January 15, 2014
Offers technical resources and information on ODT platform Read More »
By Kristin Brooks
Published January 13, 2014
Par to use oral drug delivery platform for two additional products Read More »
By Gil Roth
Published January 8, 2014
BioMarin, BMS, Catalyst, Merck, NPS, Pacira, Repros, Rexahn Read More »
By Kristin Brooks
Published January 7, 2014
To develop and commercialize DURECT’s Eladur Read More »
By Gil Roth
Published December 20, 2013
Amarin, Bristol-Myers Squibb, Cellceutix, FibroGen, MicuRx, Pfizer, Ultragenyx Read More »
By Gil Roth
Published December 19, 2013
Aethersys, Daiichi Sankyo, Galectin Therapeutics, Genzyme, GSK, NewLink Genetics, Pfizer, Sandoz, Sanofi, Theravance, Vertex Read More »
By Gil Roth
Published December 19, 2013
Approval triggers $30 million payment from Theravance, with another $30 mil. due to GSK at launch Read More »
By Kristin Brooks
Published December 6, 2013
Adds 60,000 sq. ft. at Finland site Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On